ENTITY

Revelation Biosciences (REVB US)

17
Analysis
Health Care • United States
Revelation Biosciences Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing therapeutics and diagnostics for viral infections by harnessing the power of the innate immune system. Revelation Biosciences serves customers worldwide.
more
•09 May 2026 01:00•Issuer-paid

REVB: 2026 Promises to be a Big Year

Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of...

Share
•28 Feb 2026 01:00•Issuer-paid

REVB: 2026 Begins with Financial Picture in Good Shape

Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of...

Share
•30 Jan 2026 00:00•Issuer-paid

REVB: Company Solidifies Financial Situation

Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of...

Share
•17 Jan 2026 03:00•Issuer-paid

REVB: 2026 Looks to be Good Year

Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of...

Share
•08 Nov 2025 01:00•Issuer-paid

REVB: 3Q Release Shows Company in Good Shape

Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of...

Share
x